Simplex Trading
PVLA

Simplex Trading’s Palvella Therapeutics PVLA Stock Holding History

Simplex Trading’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-191
Closed -$2K – 10120
2023
Q4 		$2K Hold
191
– – ﹤0.01% 8384
2023
Q3 		$4K Sell
191
-19
-9% -$408 ﹤0.01% 7830
2023
Q2 		$2K Buy
210
+40
+24% +$2.42K ﹤0.01% 8516
2023
Q1 		$13K Buy
170
+126
+286% +$14.6K ﹤0.01% 7343
2022
Q4 		$3K Hold
44
– – ﹤0.01% 8452
2022
Q3 		$4K Sell
44
-76
-63% -$9.8K ﹤0.01% 8992
2022
Q2 		$17K Buy
120
+22
+22% +$4.01K ﹤0.01% 7795
2022
Q1 		$23K Sell
98
-258
-72% -$67.8K ﹤0.01% 8116
2021
Q4 		$107K Buy
356
+210
+144% +$67.3K ﹤0.01% 6154
2021
Q3 		$45K Buy
146
+3
+2% +$1.04K ﹤0.01% 7640
2021
Q2 		$43K Buy
+143
New +$31.4K ﹤0.01% 7841
2020
Q1 		– Sell
-1
Closed -$22K – 8411
2019
Q4 		$22K Hold
1
– – ﹤0.01% 5888
2019
Q3 		$17K Buy
+1
New +$387 ﹤0.01% 5932

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Simplex Trading's PVLA Position: Q1 2026 in Review

Simplex Trading opened a new position in Palvella Therapeutics (PVLA) in Q1 2026: 1,622 shares worth $202K. The stake represents ﹤0.01% of the portfolio and ranks #4282 among its holdings. This is a return to the name: Simplex Trading previously reported a position in PVLA as recently as Q4 2022.

Simplex Trading first reported a position in PVLA in Q1 2018 and has held it in 12 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Simplex Trading held 1,622 shares of Palvella Therapeutics worth $202K as of Q1 2026.
  • Palvella Therapeutics was a new Simplex Trading position in Q1 2026.
  • Palvella Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4282 holding.
  • Simplex Trading first reported a position in Palvella Therapeutics in Q1 2018 and has held it in 12 quarters since.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.